HDAC9 and Miyoshi myopathy: Two HDAC inhibitors have been principally used in MM: panobinostat—a pan-HDAC inhibitor—and ricolinostat—a HDAC6 inhibitor—though other agents are also available (vorinostat, romidepsin, etc.)[51].